Cartt Stephen LaHue 4
4 · Asterias Biotherapeutics, Inc. · Filed Jun 25, 2018
Insider Transaction Report
Form 4
Cartt Stephen LaHue
DirectorPresident and CEO
Transactions
- Award
Stock Options
2018-06-21+20,000→ 20,000 totalExercise: $1.75Exp: 2028-06-21→ Common Stock (20,000 underlying)
Holdings
- 375,000
Stock Options
Exercise: $3.64Exp: 2026-02-28→ Common Stock (375,000 underlying) - 292,783
Common Stock
- 20,000
Stock Options
Exercise: $3.70Exp: 2027-06-26→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]The stock options vest equally over the next four quarters, beginning on the June 30, 2018 contingent upon continued service on the Board of Directors.
- [F2]Subject to Mr. Cartt's continued service on the Board of the Company, the stock options over four equal quarterly installments beginning on July 1, 2017. The stock options are exercisable upon vesting.
- [F3]The stock options vested and are exercisable.